We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Roles for Shock-Wave Therapy

By HospiMedica staff writers
Posted on 15 Jun 2005
Extracorporeal shock wave therapy has applications not only in orthopedics and traumatology but also in treating fresh and chronic wounds as well as circulatory disorders of the myocardial muscle, according to new findings presented at the 8th International Congress on Shock Wave Therapy in Vienna (Austria) in May 2005.

A pilot project conducted in Vienna (Austria) and Berlin (Germany) involving more than 100 patients with skin lesions resulted in more than 80% being completely healed. More...
Surveys of lobe circulation and burn models on rats at the University Clinic of Innsbruck (Austria) that were treated with shock wave therapy have shown that the therapy outclasses all previously applied treatments. In experiments on pigs, Japanese researchers were able to use the therapy to improve the circulation in myocardial muscle. The scientists speculate that the healing is due to a biochemical effect that initiates growth in blood vessels and releases growth factors.

Dr. Ching-Jen Wang (Kaoshiung, Taiwan) demonstrated a biologic response to shock wave therapy involves various proteins (growth factors), which cause an increased integration of newly formed blood vessels as well as new growth of tissue, thereby triggering the healing process that results in better circulation of the myocardial muscle, new bone formation, and formation of new skin on lesions.


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.